Skin Biopsies in Chemotherapy-Induced Neuropathy
Status
Conditions
Details and patient eligibility
About
Neuropathy is a common side effect of chemotherapeutics used for the treatment of multiple myeloma, including vincristine, thalidomide and bortezomib. The neuropathy induced by these drugs is often preferentially small fiber. Small fiber neuropathies are difficult to diagnose and quantify using conventional electromyography. Determining intra-epidermal nerve fiber density (IENFD) in skin biopsies from diabetes and AIDS patients has been shown to be a more sensitive and more specific ancillary investigation to establish the diagnosis of small fiber neuropathy. In this study the investigators aim to establish the sensitivity of IENFD measurements in skin biopsies from patients with multiple myeloma treated with bortezomib.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Patients with multiple myeloma receiving bortezomib
Exclusion criteria
- Patients not able to provide informed consent
- Patients with coagulation disturbances or immunocompromised patients
Trial design
26 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal